The loss per share amounted to €0.16 versus €11 a year earlier. Revenue rose 4.96% to €32.963 billion.
The company posted a net profit of €85 million in the third quarter compared to a loss of €2.744 billion in the same period in 2020. Earnings per share were €0.09 compared to a loss of €2.79 a year earlier. Revenue rose by 15% to €9.781 billion.
Revenues in Bayer's Pharmaceuticals division rose by 4.9% to €13.398 billion in the first nine months, the Consumer Health (OTC) division by 2.2% to €3.888 billion and the Agriculture division by 5.8% to €15.517 billion.
The company also confirmed its forecast for the year. Bayer expects revenues for the year to be in the range of €43-44 billion.
Founded in 1863, Bayer AG operates in over 300 countries with a portfolio of about 5,000 products in the fields of healthcare, crop protection and high-tech materials.
source: bloomberg.com
The company posted a net profit of €85 million in the third quarter compared to a loss of €2.744 billion in the same period in 2020. Earnings per share were €0.09 compared to a loss of €2.79 a year earlier. Revenue rose by 15% to €9.781 billion.
Revenues in Bayer's Pharmaceuticals division rose by 4.9% to €13.398 billion in the first nine months, the Consumer Health (OTC) division by 2.2% to €3.888 billion and the Agriculture division by 5.8% to €15.517 billion.
The company also confirmed its forecast for the year. Bayer expects revenues for the year to be in the range of €43-44 billion.
Founded in 1863, Bayer AG operates in over 300 countries with a portfolio of about 5,000 products in the fields of healthcare, crop protection and high-tech materials.
source: bloomberg.com